nach oben

Breast Cancer Research and Treatment

Erschienen in:

01.06.2014 | Epidemiology

Folate intake and the risk of breast cancer: a systematic review and meta-analysis

verfasst von: Martin Tio, Juliana Andrici, Guy D. Eslick

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

There is conflicting epidemiological evidence on the role of folate and breast cancer risk. We conducted a systematic review and quantitative meta-analysis of folate intake and folate blood levels and the risk of breast cancer. Four electronic databases (Medline, PubMed, Embase, and Current Contents Connect) were searched to April 11, 2014, with no language restrictions for observational studies that measured folate intake or blood levels and the risk of breast cancer. The meta-analysis of dietary folate intake comprising 36 studies with 34,602 cases, and a total sample size of 608,265 showed a decreased risk of breast cancer, with an odds ratio (OR) of 0.84 [95 % confidence interval (CI) 0.77–0.91]. When stratified by menopausal status and by study design, none of the meta-analyses of prospective studies showed any statistically significant decrease in the risk of breast cancer. The meta-analysis of total folate showed no statistically significant association with breast cancer OR of 0.98 (95 % CI 0.91–1.07). There was no significant association between either dietary or total folate intake and breast cancer when stratified by hormonal receptor status. The meta-analysis of blood folate levels found no significant association with the risk of breast cancer, with an OR of 0.86 (95 % CI 0.60–1.25). Breast cancer does not appear to be associated with folate intake, and this did not vary by menopausal status or hormonal receptor status. Folate blood levels also do not appear to be associated with breast cancer risk.

Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef

Seitz HK, Pelucchi C, Bagnardi V et al (2012) Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol 47(3):204–212PubMedCrossRef

Trichopoulos D, Adami HO, Ekbom A et al (2008) Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer 122(3):481–485PubMedCrossRef

Blount BC, Mack MM, Wehr CM et al (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosomal breakage; implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94(7):3290–3295PubMedCentralPubMedCrossRef

Stempak JM, Sohn KY, Chiang EP et al (2005) Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 26(5):981–990PubMedCrossRef

Wien TN, Pike E, Wisloff T et al (2012) Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open 12(1):e000653

Ly A, Lee H, Chen J et al (2011) Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring. Cancer Res 71(3):988–997PubMedCrossRef

Kotsopoulos J, Medline A, Renlund R et al (2005) Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis 26(9):1603–1612PubMedCrossRef

Stevens VL, McCullough ML, Sun J et al (2010) Folate and other one-carbon metabolism-related nutrients and risk of postmenopausal breast cancer in the Cancer Prevention Study II Nutrition Cohort. Am J Clin Nutr 91(6):1708–1715PubMedCrossRef

10.

Ericson U, Sonestedt E, Gullberg B et al (2007) High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort. Am J Clin Nutr 86(2):434–443PubMed

11.

Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99(1):64–76PubMedCrossRef

12.

Lewis SJ, Harbord RM, Harris R et al (2006) Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst 98(22):1607–1622PubMedCrossRef

13.

Stroup DF, Berlin JA, Morton SC et al (2000) Metaanalysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012PubMedCrossRef

14.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188PubMedCrossRef

15.

Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560PubMedCentralPubMedCrossRef

16.

Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMedCentralPubMedCrossRef

17.

Orwin R (1983) A fail safe N for effect size in meta-analysis. J Educ Stat 8:157–159CrossRef

18.

Adzersen KH, Jess P, Freivogel KW et al (2003) Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case control study in Germany. Nutr Cancer 46(2):131–137PubMedCrossRef

19.

Aune D, Deneo-Pellegrini H, Ronco AL et al (2011) Dietary folate intake and the risk of 11 types of cancer: a case control study in Uruguay. Ann Oncol 22(2):444–451PubMedCrossRef

20.

Beilby J, Ingram D, Hahnel R et al (2004) Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene. Eur J Cancer 40(8):1250–1254PubMedCrossRef

21.

Chen J, Gammon MD, Chan W et al (2005) One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 65(4):1606–1614PubMedCrossRef

22.

Cho E, Holmes M, Hankinson SE et al (2007) Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women. Cancer Epidemiol Biomarkers Prev 16(12):2787–2790PubMedCrossRef

23.

Chou YC, Lee MS, Wu MH et al (2007) Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan. Breast Cancer Res Treat 101(2):199–205PubMedCrossRef

24.

Duffy CM, Assaf A, Cyr M et al (2009) Alcohol and folate intake and breast cancer risk in the WHI Observational Study. Breast Cancer Res Treat 116(3):551–562PubMedCrossRef

25.

Ericson UC, Ivarsson MI, Sonestedt E et al (2009) Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am J Clin Nutr 90(5):1380–1389PubMedCrossRef

26.

Ericson U, Borqquist S, Ivarsson MI et al (2010) Plasma folate concentrations are positively associated with risk of estrogen receptor beta negative breast cancer in a Swedish nested case control study. J Nutr 140(9):1661–1668PubMedCrossRef

27.

Freudenheim JL, Marshall JR, Vena JE et al (1996) Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 88(6):340–348PubMedCrossRef

28.

Gao CM, Tang JH, Cao HX et al (2009) MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J Hum Genet 54(7):414–418PubMedCrossRef

29.

Graham S, Hellmann R, Marshall J et al (1991) Nutritional epidemiology of postmenopausal breast cancer in western New York. Am J Epidemiol 134(6):552–566PubMed

30.

Kabat GC, Miller AB, Jain M et al (2008) Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer 99(5):816–821PubMedCentralPubMedCrossRef

31.

Kotsopoulos J, Sukiennicki G, Muszynska M et al (2012) Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study. Cancer Causes Control 23(7):1065–1074PubMedCrossRef

32.

Lajous M, Lazcano-Ponce E, Hernandez-Avila M et al (2006) Folate, vitamin B₆, and vitamin B₁₂ intake and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(3):443–448PubMedCrossRef

33.

Lajous M, Romieu I, Sabia S et al (2006) Folate, vitamin B₁₂ and postmenopausal breast cancer in a prospective study of French women. Cancer Causes Control 17(9):1209–1213PubMedCentralPubMedCrossRef

34.

Larsson SC, Berqkvist L, Wolk A (2008) Folate intake and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Epidemiol Biomarkers Prev 17(12):3444–3449PubMedCrossRef

35.

Lee SA, Lee KM, Lee SJ et al (2010) Antioxidant vitamins intake, ataxia telangiectasia mutated (ATM) genetic polymorphisms, and breast cancer risk. Nutr Cancer 62(8):1087–1094PubMedCrossRef

36.

Levi F, Pasche C, Lucchini F et al (2001) Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 91(2):260–263PubMedCrossRef

37.

Lin J, Lee IM, Cook NR et al (2008) Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr 87(3):734–743PubMed

38.

Ma E, Iwasaki M, Junko I et al (2009) Dietary intake of folate, vitamin B₆, and vitamin B₁₂, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 9:122PubMedCentralPubMedCrossRef

39.

Ma E, Iwasaki M, Kobayashi M et al (2009) Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer 61(4):447–456PubMedCrossRef

40.

Maruti SS, Ulrich CM, White E (2009) Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 89(2):624–633PubMedCentralPubMedCrossRef

41.

Negri E, La Vecchia C, Franceschi S (2000) Re: dietary folate consumption and breast cancer risk. J Natl Cancer Inst 92(15):1270–1271PubMedCrossRef

42.

Potischman N, Swanson CA, Coates RJ et al (1999) Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer 82(3):315–321PubMedCrossRef

43.

Rohan TE, Jain MG, Howe GR et al (2000) Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 92(3):266–269PubMedCrossRef

44.

Roswall N, Olsen A, Christensen J et al (2010) Micronutrient intake and breast cancer characteristics among postmenopausal women. Eur J Cancer Prev 19(5):360–365PubMedCrossRef

45.

Sellers TA, Kushi LH, Cerhan JR et al (2001) Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 12(4):420–428PubMedCrossRef

46.

Sellers TA, Vierkant RA, Cerhan JR et al (2002) Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11:1104–1107PubMed

47.

Sellers TA, Gabrick DM, Vierkant RA et al (2004) Does folate intake decrease risk of postmenopausal breast cancer among women with a family history? Cancer Causes Control 15(2):113–120PubMedCrossRef

48.

Sharp L, Little J, Schofield AC et al (2002) Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett 181(1):65–71PubMedCrossRef

49.

Shrubsole MJ, Jin F, Dai Q et al (2001) Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res 61(19):7136–7141PubMed

50.

Shrubsole MJ, Shu XO, Li HL et al (2011) Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol 173(10):1171–1182PubMedCentralPubMedCrossRef

51.

Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF et al (2006) Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 83(4):895–904PubMed

52.

Suzuki T, Matsuo K, Hirose K et al (2008) One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29(2):356–362PubMedCrossRef

53.

Thorand B, Kohlmeier L, Simonsen N et al (1998) Intake of fruits, vegetables, folic acid, and related nutrients and risk of breast cancer in postmenopausal women. Public Health Nutr 1(3):147–156PubMedCrossRef

54.

Wu K, Helzlsouer KJ, Comstock GW et al (1999) A prospective study on folate, B12, and pyridoxal 5′-phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev 8(3):209–217PubMed

55.

Yang YJ, Hwang SH, Kim HJ et al (2010) Dietary intake of nitrate relative to antioxidant vitamin in relation to breast cancer risk: a case-control study. Nutr Cancer 62(5):555–566PubMedCrossRef

56.

Zhang S, Hunter DJ, Hankinson SE et al (1999) A prospective study of folate intake and the risk of breast cancer. JAMA 281(17):1632–1637PubMedCrossRef

57.

Zhang SM, Willett WC, Selhub J et al (2003) Plasma folate, vitamin B₆, vitamin B₁₂, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95(5):373–380PubMedCrossRef

58.

Zhang SM, Hankinson SE, Hunter DJ et al (2005) Folate intake and risk of breast cancer characterized by hormone receptor status. Cancer Epidemiol Biomarkers Prev 14(8):2004–2008PubMedCrossRef

59.

Zhang CX, Ho SC, Chen YM et al (2011) Dietary folate, vitamin B₆, vitamin B₁₂, and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status. Br J Nutr 106(6):936–943PubMedCrossRef

60.

Zhu K, Davidson NE, Hunter S et al (2003) Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes. Cancer Causes Control 14(9):827–836PubMedCrossRef

61.

Bassett JK, Baglietto L, Hodge AMm et al (2013) Dietary intake of B vitamins and methionine and breast cancer risk. Cancer Causes Control 24(8):1555–1563PubMedCrossRef

62.

Gong Z, Ambrosone CB, McCann SE et al (2014) Associations of dietary folate, Vitamins B6 and methionine intake with risk of breast cancer among African American and European American women. Int J Cancer 134(6):1422–1435PubMedCrossRef

63.

Islam T, Ito H, Sueta A et al (2013) Alcohol and dietary folate intake and the risk of breast cancer: a case-control study in Japan. Eur J Cancer Prev 22(4):358–366PubMedCrossRef

64.

Yang D, Baumgartner RN, Slattery ML et al (2013) Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women. PLoS One 8(2):e54495PubMedCentralPubMedCrossRef

65.

Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR et al (2011) Dietary supplement use in the United States, 2003–2006. J Nutr 141(2):261–266PubMedCentralPubMedCrossRef

66.

Skeie G, Braaten T, Hjartaker A, Lentjes M, Amiano P, Jakszyn P et al (2009) Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr 63(S4):S226–S238PubMedCrossRef

Titel: Folate intake and the risk of breast cancer: a systematic review and meta-analysis
verfasst von: Martin Tio
Juliana Andrici
Guy D. Eslick
Publikationsdatum: 01.06.2014
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 2/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-014-2969-8

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Folate intake and the risk of breast cancer: a systematic review and meta-analysis

Abstract

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study

Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort

Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling

Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristics

Erratum to: Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy

A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie